Press "Enter" to skip to content

Bristol-Myers wins $752 million in U.S. patent case against Gilead

Bristol-Myers Squibb Co on Friday said it won a $752 million jury verdict against Gilead Sciences Inc in a U.S. patent dispute relating to technology for treating cancer.

Original source:

Also Read:   Ratan Tata invests in 18-yr-old’s start-up Generic Aadhaar